Join this facilitated group discussion on the impact of the life science sector boom on CRE, including its current boom state and how long the momentum will last. How can Tier 2 and 3 cities support the life sciences sector and keep up with established biotech hubs? Are clients putting a premium on buildings that focus on wellness and good workflow?
Bring your questions and best practices to this conversation.
Facilitator: Kerry Hawkins, Senior Director, Life Science Investment Management, Greystar Life Science